Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus
NCT02701608Phase 3Completed
- Sponsor
- University Hospital Tours
- Start
- Feb 2016
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin, rifampicin in infective endocarditis (IE), sponsored by University Hospital Tours. Started Feb 2016; status: completed.
02
Drugs
levofloxacinrifampicin
03
Conditions
infective endocarditis (IE)
Beyond the preview
Go deeper on NCT02701608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02701608.